Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04458922
Title Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of Florida Health Science Center - Gainesville Gainesville Florida 32610 United States Details
Emory University Hospital Midtown Atlanta Georgia 30308 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
National Cancer Institute Developmental Therapeutics Clinic Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Siteman Cancer Center-South County Saint Louis Missouri 63129 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
University Health Network-Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field